AMP-activated protein kinase: An attractive therapeutic target for ischemia-reperfusion injury

Rong Ding,Wei Wu,Zhou Sun,Zhi Li

DOI: https://doi.org/10.1016/j.ejphar.2020.173484

IF: 5.195

2020-12-01

European Journal of Pharmacology

Abstract:<p>Ischemia-reperfusion (I/R) injury is a major cause of morbidity and mortality worldwide. AMP-activated protein kinase (AMPK) is an energy sensor that regulates metabolic homeostasis. A growing body of literature has shown that AMPK activation exerts protective effects against I/R injury in heart, brain, kidney, liver, lung and intestine. In this review, we first reveal the mechanisms underlying the protective effects of AMPK activation against I/R injury in preclinical studies. We found that AMPK activation attenuates I/R injury via regulation of energy metabolism, oxidative stress, mitochondrial function, autophagy, inflammatory response, and endoplasmic reticulum stress. Then, current therapeutic strategies (e.g., metformin, adiponectin) used to ameliorate I/R injury by modulating AMPK activity are reviewed in detail. Collectively, pharmacological activation of AMPK may hold a unique therapeutic potential in the prevention and attenuation of I/R injury.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper aims to explore the protective role and potential mechanisms of AMP-activated protein kinase (AMPK) in ischemia-reperfusion (I/R) injury and to evaluate the therapeutic potential of pharmacologically activating AMPK to prevent and mitigate I/R injury.

Specifically, the paper focuses on the following aspects:
1. **Energy Metabolism Regulation**: AMPK maintains energy balance by promoting glucose uptake and glycolysis, inhibiting fatty acid synthesis, and increasing fatty acid oxidation, thereby playing a protective role in I/R injury.
2. **Oxidative Stress Regulation**: AMPK can reduce excessive generation of reactive oxygen species (ROS), inhibit the upregulation of NADPH oxidase, and enhance the antioxidant activity mediated by nuclear factor erythroid 2-related factor 2 (Nrf2), thereby alleviating oxidative stress.
3. **Mitochondrial Function Regulation**: AMPK helps improve mitochondrial dysfunction, reduce mitochondrial ROS production, and protect the myocardium from I/R injury by regulating signaling pathways such as FoxO3a and SIRT3.
4. **Autophagy Regulation**: AMPK promotes autophagy by inhibiting mTOR and activating ULK1, which helps clear damaged organelles and alleviate I/R injury.
5. **Inflammatory Response Regulation**: AMPK inhibits inflammatory responses by suppressing signaling pathways such as JNK and NF-κB, thereby reducing tissue damage after I/R.
6. **Endoplasmic Reticulum Stress Regulation**: AMPK can reduce cell apoptosis by inhibiting endoplasmic reticulum stress, thereby mitigating I/R injury.

In addition, the paper introduces several pharmacological AMPK activators (such as AICAR, metformin, and the adenosine monophosphate-activated protein kinase agonist A-769662) and their effects in I/R injury, discussing specific evidence of these drugs exerting protective effects through AMPK-dependent mechanisms. In summary, pharmacological activation of AMPK may become a method with unique therapeutic potential for preventing and mitigating I/R injury.